Skip to main content
Premium Trial:

Request an Annual Quote

UCLA's Pancreatic Center Taps SiDMAP's Founders for Metabolomic Profiling

NEW YORK (GenomeWeb News) – SiDMAP’s co-founders will perform metabolomics profiling for pancreatic studies run by the University of California, Los Angeles, and funded by the National Institutes of Health, the company said last week.
The company said that Paul Lee and Laszlo Boros will work with UCLA’s Center for Excellence in Pancreatic Medicine, which in October was named a National Center for Excellence by the National Center for Complementary and Alternative Medicine, and received over $5.6 million to study various pancreatic diseases.
The SiDMAP tracer technology measures metabolic pathway flux to gain insights into cell function, the privately held firm said.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.